Latest Machine Learning News

IMDEX has acquired an 80.5% stake in Norway’s Earth Science Analytics for A$26 million, integrating its AI-driven EarthNET platform to boost digital orebody knowledge across mining and energy sectors.

WhiteHawk Limited has completed a A$2 million share placement aimed at advancing its AI and machine learning automation capabilities and supporting new US cyber governance contracts.

BlinkLab is advancing its FDA 510(k) clinical trials for autism and ADHD diagnostics, completing its U.S. autism pilot phase and expanding European ADHD recruitment. A recent $7.66 million capital raise supports these efforts as the company targets regulatory approvals in 2026.

Linius Technologies has landed a paid Proof of Concept with a leading European soccer league, aiming to showcase its video search and assembly platform to boost fan engagement. This deal could open doors to significant Tier 1 contracts in the lucrative European football market.

4DMedical has renewed its three-year contract with the University of Michigan Medical Center, reinforcing its foothold in US respiratory imaging. Alongside, a pivotal clinical study validates its technology’s ability to detect early lung disease, while a substantial Australian grant boosts its AI research.

Ava Risk Group reports a 5% revenue increase and a positive EBITDA turnaround in FY25, underpinned by its advanced security technologies. The company eyes over $88 million in FY26 sales opportunities despite some project delays.

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.

InFocus Group Holdings has extended its convertible note facility with Obsidian Global, unlocking up to AUD 450,000 to accelerate growth in digital assets, AI, and machine learning.

Copper Search Limited has secured two key exploration licences in South Australia's Eromanga Basin for Heavy Mineral Sands, setting the stage for a fully funded drilling campaign later this year. The company is also progressing copper-gold projects in New South Wales with government co-funding applications underway.

Optiscan Imaging Ltd has commenced a landmark clinical study at Royal Melbourne Hospital, testing its cutting-edge InVue® and InForm™ devices to improve breast cancer surgery precision. The study aims to generate critical data for US FDA approval and could redefine surgical oncology workflows.

BlinkLab has secured US Institutional Review Board approval to proceed with the main phase of its FDA 510(k) trial for an AI-powered autism diagnostic tool, marking a key step toward regulatory clearance.

White Energy has identified five distinct target zones with anomalous copper, zinc, nickel, gold, and rare earth elements in soil samples over geophysical structures at its Tindal project in the Northern Territory, signaling promising early-stage exploration results.